Comprehensive molecular portraits of human breast tumours Brigham & Women¡¯s Hospital & Harvard Medical School Chin Lynda 9 11 Park ... Nature 490 (7418), 61-70, 2012 | 11485 | 2012 |
Comprehensive molecular characterization of human colon and rectal cancer Cancer Genome Atlas Network Nature 487 (7407), 330, 2012 | 7753 | 2012 |
Integrated genomic analyses of ovarian carcinoma D Bell, A Berchuck, M Birrer, J Chien, DW Cramer, F Dao, R Dhir, P Disaia, ... Nature Publishing Group 474 (7353), 609-615, 2011 | 7111 | 2011 |
Integrated genomic characterization of endometrial carcinoma DA Levine, ... Nature 497 (7447), 67-73, 2013 | 5184 | 2013 |
Comprehensive genomic characterization of squamous cell lung cancers Cancer Genome Atlas Research Network Nature 489 (7417), 519, 2012 | 3788 | 2012 |
Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM CJ Vaske, SC Benz, JZ Sanborn, D Earl, C Szeto, J Zhu, D Haussler, ... Bioinformatics 26 (12), i237-i245, 2010 | 910 | 2010 |
Distributed machine learning systems, apparatus, and methods C Szeto, SC Benz, NJ Witchey US Patent 11,461,690, 2022 | 288 | 2022 |
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition GS Wong, J Zhou, JB Liu, Z Wu, X Xu, T Li, D Xu, SE Schumacher, ... Nature medicine 24 (7), 968-977, 2018 | 255 | 2018 |
The UCSC cancer genomics browser J Zhu, JZ Sanborn, S Benz, C Szeto, F Hsu, RM Kuhn, D Karolchik, ... Nature methods 6 (4), 239-240, 2009 | 202 | 2009 |
A deep learning image-based intrinsic molecular subtype classifier of breast tumors reveals tumor heterogeneity that may affect survival MI Jaber, B Song, C Taylor, CJ Vaske, SC Benz, S Rabizadeh, ... Breast Cancer Research 22, 1-10, 2020 | 95 | 2020 |
The UCSC cancer genomics browser: update 2011 JZ Sanborn, SC Benz, B Craft, C Szeto, KM Kober, L Meyer, CJ Vaske, ... Nucleic acids research 39 (suppl_1), D951-D959, 2011 | 74 | 2011 |
The multi-functionality of N-809, a novel fusion protein encompassing anti-PD-L1 and the IL-15 superagonist fusion complex C Jochems, SR Tritsch, KM Knudson, SR Gameiro, CS Rumfield, ... Oncoimmunology 8 (2), e1532764, 2019 | 38 | 2019 |
Large scale, robust, and accurate whole transcriptome profiling from clinical formalin-fixed paraffin-embedded samples Y Newton, AJ Sedgewick, L Cisneros, J Golovato, M Johnson, CW Szeto, ... Scientific reports 10 (1), 17597, 2020 | 32 | 2020 |
Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status F Loupakis, G Maddalena, I Depetris, S Murgioni, F Bergamo, AP Dei Tos, ... Journal for ImmunoTherapy of Cancer 7, 1-7, 2019 | 32 | 2019 |
Transcriptomic silencing as a potential mechanism of treatment resistance JJ Adashek, S Kato, R Parulkar, CW Szeto, JZ Sanborn, CJ Vaske, ... JCI insight 5 (11), 2020 | 27 | 2020 |
Molecular basis of a dominant SARS-CoV-2 spike-derived epitope presented by HLA-A* 02: 01 recognised by a public TCR C Szeto, AT Nguyen, CA Lobos, DSM Chatzileontiadou, D Jayasinghe, ... Cells 10 (10), 2646, 2021 | 22 | 2021 |
Ensemble-Based Research Recommendation Systems And Methods C Szeto US Patent App. 15/555,290, 2018 | 18 | 2018 |
Association of differential expression of immunoregulatory molecules and presence of targetable mutations may inform rational design of clinical trials CW Szeto, R Kurzrock, S Kato, A Goloubev, S Veerapaneni, A Preble, ... ESMO open 7 (1), 100396, 2022 | 13 | 2022 |
Systems and methods for response prediction to chemotherapy in high grade bladder cancer C Szeto US Patent 11,101,038, 2021 | 13 | 2021 |
Complete response to avelumab and IL-15 superagonist N-803 with Abraxane in Merkel cell carcinoma: a case study L Drusbosky, C Nangia, A Nguyen, C Szeto, Y Newton, P Spilman, ... Journal for immunotherapy of cancer 8 (2), 2020 | 13 | 2020 |